Filing Flows › Zymeworks (ZYME) › Q2 2026
Zymeworks (ZYME) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Zymeworks (ZYME) reported revenue of $4.6M for the second quarter 2026 (Q2 2026), -91% from a year earlier and +91% from the quarter before. Operating margin was -919.0%, net loss $45.0M (980.8% of revenue).
Zymeworks, Q2 2026: revenue $4.6M (-91% year over year), operating margin -919.0%, net loss $45.0M, operating cash flow −$31.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.6M | +91% | -91% |
| Operating profit | −$42.2M | — | — |
| Net earnings | −$45.0M | — | -2043% |
| Operating cash flow | −$31.9M | — | -365% |
What changed
Revenue was $4.6M in Q2 2026, down 91% year over year and up 91% from the previous quarter.
Operating costs exceeded revenue by $42.2M, an operating margin of -919.0%. Total costs fell 5% while revenue fell 91%. The fastest-growing cost line was General & admin (+29%). The quarter ended with a net loss of $45.0M, wider than the previous quarter's $44.2M loss.
Operating cash flow was −$31.9M. Non-cash charges added back $1.1M of depreciation and amortization and $11.3M of share-based compensation.
Questions
What was Zymeworks' revenue in the second quarter 2026?
Zymeworks (ZYME) reported revenue of $4.6M for the second quarter 2026 (Q2 2026), -91% from a year earlier and +91% from the quarter before.
Was Zymeworks profitable in the second quarter 2026?
Operating loss was $42.2M (-919.0% of revenue) and net loss $45.0M.
Source: Zymeworks 10-Q on SEC EDGAR.